Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TKO Group Holdings Inc (TKO) vs Twist Bioscience Corp (TWST) Price & Performance

TKO Group Holdings IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

TKO Group Holdings Inc vs Twist Bioscience Corp — how do they compare? TKO Group Holdings Inc trades at $181.02 (market cap $13.06B), while Twist Bioscience Corp trades at $157.11 (market cap $10.32B). The key difference: TKO Group Holdings Inc is the larger of the two by market cap, and TKO Group Holdings Inc pays a 1.77% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold TKO Group Holdings Inc for 30 Days and Twist Bioscience Corp for 27 Days on average.

TKOTWST
Market Cap
$13.06B$10.32B
Volume
999,9065,894,998
Sector
MediaHealth
52-Week High
$224.96$205.00
52-Week Low
$175.58$25.45
Typical Hold Time
30 Days27 Days
Enterprise Value
$17.42B$10.24B
Dividend Yield
1.77%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TKO Group Holdings Inc

TKO trades at $178.64, down 1.24% on the day and near a 52-week low of $174.58 (Defense World, 2026-10-02). The stock is technically bearish with mixed earnings, missing Q2 2026 EPS estimates but beating Q1. Revenue growth is solid, with 2026 guidance raised to $5.3B, though high P/E of 62.68 signals premium valuation. A quarterly dividend of $0.79 was declared for September 2026.

Outlook is supported by strong analyst consensus (89% buy ratings) and a $227 price target, but risks include recent technical weakness, margin pressure, and competitive threats. The stock offers upside if media rights and live event execution drive earnings growth, yet volatility near lows warrants caution.

Twist Bioscience Corp

TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.

The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TKO
100% Buy0% Sell
Avg holding period · 30 Days
TWST
37% Buy63% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About TKO Group Holdings Inc

TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.

Read more on TKO →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →